Lasolex Liquid Solution

Manufacturer
PureTek Corporation
Effective date
2026-03-24
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:51:21

Label at a glance#

ProductLasolex Liquid Solution
Active ingredientCLOTRIMAZOLE
Label structure10 sections

Indications and uses

For treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis) Relieves itching, scaling, cracking, burning and discomfort. Also helps relieve chafing associated with jock itch, itchy, scaly skin between the toes, or itching, burning feet.

Dosage and administration

■ Clean the affected area and dry thoroughly. ■ Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a licensed healthcare practitioner ■ Supervise children in the use of this product. ■ For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. ■ For athlete's foot and ...

Storage and handling

■ Store at 15° to 30° (59° to 86°F) ■ Protect from freezing and excessive heat ■ Do not use if package is damaged

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Clotrimazole 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • For treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis)
  • Relieves itching, scaling, cracking, burning and discomfort.
  • Also helps relieve chafing associated with jock itch, itchy, scaly skin between the toes, or itching, burning feet.

Warnings

WARNINGS SECTION

For external use only.

Do not use on children under 2 years of age

When using this product • avoid contact with eyes

Stop use and ask a doctor if
• for athlete's foot and ringworm, if irritation occurs or if there is no improvement within 4 weeks, discontinue use and consult a licensed healthcare practitioner
• for jock itch, if irritation occurs or if there is no improvement in 2 weeks, discontinue use and consult a licensed healthcare practitioner

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

■ Clean the affected area and dry thoroughly.
■ Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a licensed healthcare practitioner
■ Supervise children in the use of this product.
■ For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily.
■ For athlete's foot and ringworm, use daily for 4 weeks.

■ For jock itch, use daily for 2 weeks.

■ If condition persists longer, consult alicensed healthcare practitioner.

■ This product is not effective on the scalp or nails.

Other information

STORAGE AND HANDLING SECTION

■ Store at 15° to 30° (59° to 86°F)

■ Protect from freezing and excessive heat

■ Do not use if package is damaged

Inactive ingredient

INACTIVE INGREDIENT SECTION

Argania Spinosa (Argan) Kernel Oil, Benzyl Alcohol, DL-Alpha-Tocopheryl-Acetate, Eucalyptus Globulus (Eucalyptus) Leaf Oil, Glycerin, Lavandula Angustifolia (Lavender) Oil, Melaleuca Alternifolia (Tea Tree) Leaf Oil, PEG-8.

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-877-921-0141

SPL UNCLASSIFIED SECTION

Keep this and all medications out of the reach of children.

Manufactured by:
PureTek Corporation
Panorama City, 91402
For questions or information
call toll-free: 1-877-921-7873

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Drug FactsDrug Facts

labellabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
309370clotrimazole 1 % Topical SolutionPSN1
2739324Lasolex Liquid 1 % Topical SolutionPSN1
2739324clotrimazole 10 MG/ML Topical Solution [Lasolex Liquid]SBD1
309370clotrimazole 10 MG/ML Topical SolutionSCD1
309370clotrimazole 1 % Topical SolutionSY1
2739324Lasolex Liquid 1 % Topical SolutionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CLOTRIMAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b64d2752-34ef-378a-1f4f-8bff32b0d1aeProduct name420250626
cb7783e0-feaa-7e56-fb3b-d43b6efa77c9Product name220250121
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
9869efd7-d6dd-0665-5b67-53adbe6ef15eProduct name120140508
f5395dd2-4395-d8c6-3477-8c2d4a2f951cProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59088-251-03Lasolex Liquid Solution30 mL in 1 BOTTLE, WITH APPLICATORSOLUTION301

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59088-251-03ML - Milliliter59088-251e4c44002-14da-4f4d-a4d7-2196ba8415bd12026-04-20

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59088-25159088-251-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lasolex Liquid SolutionCLOTRIMAZOLE 1%PureTek Corporation4dc9e64d-8235-b218-e063-6394a90a01572026-03-24WarningsExact identifier
ndc (package): 59088-251-03
ndc (product): 59088-251
ndc11 (package): 59088025103
spl id: 4dc9e65a-242c-c059-e063-6394a90a9344
spl set id: 4dc9e64d-8235-b218-e063-6394a90a0157

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.